Say when is a research study being conducted by the San Francisco Department of Public Health. The purpose of this study is to find out what effects naltrexone taken on an as-needed basis has on your alcohol use.
We ultimately want to learn whether medications can help people to reduce their alcohol use, as well as associated high-risk behaviors such as unprotected sex.
Prior studies suggest that the medication we are testing may reduce heavy alcohol use. Specifics of the medication will be explained to you during the screening process. However, it is important to understand that we do not yet know if this medication will lead to a reduction in binge-drinking. Because this study is double-blind and randomized, you would receive either the medication or placebo; all participants will receive weekly harm-reduction counseling.
If you are eligible and choose to enroll in the study, you will be randomized to the medication or placebo which you will take on an as needed basis in anticipation of drinking. During that time you would come in every week for counseling, questionnaires and clinical exams. You will be paid for every visit. You will also receive brief, daily text messages asking you if you took your medication. You will be paid each day you respond to these text messages. You can earn up to $559 for participating in this study.
Neither you nor the study staff will know if you are receiving the medication or placebo (both the medication and placebo look exactly the same). You will be monitored for any reactions you may have to the study drug and the study clinician will be readily available to discuss any issues you may have. After the study has been fully enrolled and completed, we will contact each participant and inform you if you received the medication or the placebo.
Call us at 415-437-6333 or send us your contact information using the contact form on this page to see if you might qualify. If you do, we will set up the first screening visit for you to come in to our office to see if you meet further study criteria. Determining study eligibility involves meeting with counselors and clinical staff, answering questions, having a physical exam, and giving a urine sample.
As a study participant, you are free to end your participation at any time. Study staff will work with you to accommodate any difficulties you have in making study visits.
Say When is open to individuals regardless of HIV status.